AKO-B vs PSMT

The Advanced Deterministic Scorecard reveals a deeply concerning Piotroski F-Score of 0/9, indicating severe financial health weaknesses, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite this, the company demonstrates strong profitability with a 24.73% ROE and solid 36.3% YoY earnings growth, supported by a robust 4.41% dividend yield and 70% dividend strength. Valuation appears mixed: trading at a P/E of 16.44 below sector average, yet far above the Graham Number of $224.66 when adjusted for currency context, suggesting potential overvaluation. Technical trend is weak at 10/100, and insider sentiment is lukewarm, offsetting strong recent price performance (+67.2% 1Y).

PSMT exhibits a stable but mediocre financial health profile with a Piotroski F-Score of 4/9 and a Graham Number of $71.11, indicating the stock is currently trading at a significant premium. While the company maintains a very healthy Debt/Equity ratio (0.24) and consistent revenue growth (~9.7%), the current price of $161.78 far exceeds both the Graham Number and the growth-based Intrinsic Value of $123.95. Bearish insider activity and thin profit margins (2.82%) offset the strong 1-year price momentum, suggesting the stock may be overextended.